AgomAb Therapeutics NV American Depositary Shares (AGMB)
AgomAb Therapeutics NV American Depositary Shares (AGMB) is listed on Nasdaq, where it has traded since February 6, 2026.
- Listed On
- Nasdaq
- Listed Since
- February 6, 2026
- Employees
- 62
- Market Cap
- $518M
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 34 institutions reported holding AGMB, with 26.0 million shares worth $337.0 million in aggregate. The largest reported holder was Eqt Fund Management S.a R.L, with 5.1 million shares worth $66.7 million. Of the 5 largest holders listed below, 1 added shares and 4 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Eqt Fund Management S.a R.L | 5,141,992 | $67M | Unchanged |
| Sanofi | 2,783,096 | $36M | Unchanged |
| Redmile Group | 2,733,926 | $35M | Added 1649.71% |
| Cormorant Asset Management | 2,465,348 | $32M | Unchanged |
| Tcg Crossover Management | 2,053,233 | $27M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AGMB?
AgomAb Therapeutics NV American Depositary Shares (AGMB) is listed on Nasdaq, where it has traded since February 6, 2026.
Who are the largest institutional holders of AGMB?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AGMB were Eqt Fund Management S.a R.L, Sanofi and Redmile Group.
How many institutions own AGMB?
34 institutions reported a position in AGMB for the quarter ended June 30, 2026, worth $337.0 million in total.
Did institutions buy or sell AGMB last quarter?
Of the 5 largest reported holders, 1 added shares and 4 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AGMB.
Every reported institutional holder, plus insider and congressional trades in AGMB, on SentiSense.